SSH - ST LOUIS INC. — History
CCN 262013 | 3-year financial timeline | COVID resilience: 59/100
🛡️ Public data only — no PHI permitted on this instance.
$45M
Latest Revenue (FY2022)
+11.6%
Revenue CAGR (3yr)
0.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $36M | $44M | $45M | +4.3% | +11.6% |
| Operating Expenses | $35M | $39M | $45M | +16.2% | +14.0% |
| Operating Margin | 4.4% | 10.6% | 0.4% | -96.2% | -69.7% |
| Net Income | $2M | $5M | $0M | -96.0% | -66.2% |
| Licensed Beds | 71 | 71 | 71 | +0.0% | +0.0% |
| Total Patient Days | 18,607 | 20,256 | 21,417 | +5.7% | +7.3% |
| Medicare Day % | 47% | 40% | 37% | -7.7% | -10.9% |
| Medicaid Day % | 5% | 1% | 3% | +103.6% | -25.5% |
COVID Impact & Recovery
Resilience Score: 59/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +24.7% ($36M → $45M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.6%
This Hospital
+7.6%
State Avg
Latest Margin
0.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $50M | -1.6% |
| FY2024 (proj) | $54M | -3.6% |
| FY2025 (proj) | $59M | -5.6% |